This may explain why stage III and IV MSI-H CRC did not manifest a better survival, it might be because the immune system has completely lost the fight against tumor cells who overexpressed PD-1 and CTLA-4, and then metastasis began [49–51]. This evidence concerns the gene PDCD1 and colorectal carcinoma.